The APAC ECMO market is expected to grow from US$ 110.85 million in 2022 to US$ 139.19 million by 2028. It is estimated to record a CAGR of 3.9% from 2022 to 2028.
The employment of ECMO for treating respiratory failure has been increasing in recent years, as treatments with ECMO show promising survival rates. Further, ECMO is recommended to treat patients suffering from acute respiratory distress syndrome (ADRS), primary graft dysfunction post lung transplant, and trauma to the lungs as it increases the survival rate of patients. Furthermore, ECMO increases the survival rate of patients affected by post-cardiac arrest regimen. A radical shift in adopting westernized lifestyles leads to various cardiac disorders. Thus, key players invest significantly in R&D, which results in improved treatment outcomes with ECMO with an increased survival rate. Therefore, the rising survival rate with ECMO use in various treatments is expected to provide lucrative opportunities for ECMO market in APAC during the forecast period.
Increasing Survival Rates with ECMO to Offer Opportunities for APAC ECMO Market
During 2022-2028The employment of ECMO for treating respiratory failure has been increasing in recent years, as treatments with ECMO show promising survival rates. Further, ECMO is recommended to treat patients suffering from acute respiratory distress syndrome (ADRS), primary graft dysfunction post lung transplant, and trauma to the lungs as it increases the survival rate of patients. Furthermore, ECMO increases the survival rate of patients affected by post-cardiac arrest regimen. A radical shift in adopting westernized lifestyles leads to various cardiac disorders. Thus, key players invest significantly in R&D, which results in improved treatment outcomes with ECMO with an increased survival rate. Therefore, the rising survival rate with ECMO use in various treatments is expected to provide lucrative opportunities for ECMO market in APAC during the forecast period.
APAC ECMO Market Overview
APAC is the fastest-growing regional ECMO market. China, India, and Japan are major contributors to the APAC ECMO market growth in the region. China dominated the market in 2022. According to an article by the National Center for Biotechnology Information (NCBI) titled "Cardiovascular Health and Diseases in China," Cardiovascular Disease (CVD) accounted for ~47% and 44% of all deaths in rural and urban areas, respectively, in 2019. Two out of every five deaths occur due to CVD, and it is predicted that over 330 million patients suffer from CVD in China. The patients suffering from stroke, heart failure, coronary heart disease, pulmonary heart disease, rheumatic heart disease, atrial fibrillation, lower extremity artery disease, congenital heart disease, and hypertension were found to be 13 million, 11 million, 9 million, 5 million, 4.87 million, 2.50 million, 2 million, 45.30 million, and 245.00 million, respectively. Moreover, according to Statista data, the population aged above 60 years is estimated to grow from 17.4% in 2020 to 30% by 2040. Thus, China is facing the pressures of an aging population and the constant rise in the prevalence of metabolic risk factors. As a result, the CVD burden will continue to increase, setting new requirements for CVD prevention, treatment, and the allocation of medical resources in China. Furthermore, the penetration of international market players in the country is boosting the growth of the ECMO market. In July 2021, Xenios AG, a Fresenius Medical Care company, received approval from the National Medical Products Administration (NMPA) in China for the Xenios console and patient kits for ECMO therapy. Hence, the rising prevalence of CVD, the increasing geriatric population, and advancements by key players are expected to propel the ECMO market in China during the forecast period.APAC ECMO Market Segmentation
The APAC ECMO market is segmented based on modality, application, age group, and country.- Based on modality, the APAC ECMO market is segmented into venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO. The venoarterial ECMO segment held the largest market share in 2022.
- Based on application, the APAC ECMO market is bifurcated into respiratory and cardiology. The respiratory segment held a larger market share in 2022.
- Based on age group, the APAC ECMO market is segmented into adults, pediatrics, and neonates. The adults segment held the largest market share in 2022.
- Based on country, the APAC ECMO market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of APAC. Our regional analysis states that China dominated the market in 2022.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC ECMO Market - By Modality
1.3.2 APAC ECMO Market - By Application
1.3.3 APAC ECMO Market - By Age Group
1.3.4 APAC ECMO Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC ECMO Market - Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC ECMO Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Cardiovascular Diseases and Respiratory Failures
5.1.2 Growing Adoption of ECMO in Lung Transplantation Procedures
5.2 Market Restraints
5.2.1 Complications Associated with ECMO
5.3 Market Opportunities
5.3.1 Increasing Survival Rates with ECMO
5.4 Future Trends
5.4.1 Surging Product Developments and Approvals
5.5 Impact Analysis
6. ECMO Market - APAC Analysis
6.1 APAC ECMO Market Revenue Forecast & Analysis
7. APAC ECMO Market Analysis - By Modality
7.1 Overview
7.2 APAC ECMO Market Share by Modality 2021 & 2028 (%)
7.3 Venoarterial ECMO
7.3.1 Overview
7.3.2 Venoarterial ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
7.4 Venovenous ECMO
7.4.1 Overview
7.4.2 Venovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
7.5 Arteriovenous ECMO
7.5.1 Overview
7.5.2 Arteriovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
8. APAC ECMO Market Analysis - By Application
8.1 Overview
8.2 APAC ECMO Market, By Application 2021 & 2028 (%)
8.4 Respiratory
8.4.1 Overview
8.4.2 Respiratory Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Cardiology
8.5.1 Overview
8.5.2 Cardiology Market Revenue and Forecast to 2028 (US$ Mn)
9. APAC ECMO Market Analysis - By Age Group
9.1 Overview
9.2 APAC ECMO Market, By Age Group 2021 & 2028 (%)
9.3 Adults
9.3.1 Overview
9.3.2 Adults Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Pediatrics
9.4.1 Overview
9.4.2 Pediatrics Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Neonates
9.5.1 Overview
9.5.2 Neonates Market Revenue and Forecast to 2028 (US$ Mn)
10. APAC ECMO Market - Country Analysis
10.1 Overview
10.1.1 APAC: ECMO Market, by Country, 2021 & 2028 (%)
10.1.1.1 China: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 China: ECMO Market, by Modality, 2020-2028 (US$ Million)
10.1.1.1.4 China: ECMO Market, by Application, 2020-2028 (US$ Million)
10.1.1.1.5 China: ECMO Market, by Age Group, 2020-2028 (US$ Million)
10.1.1.2 Japan: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Japan: ECMO Market, by Modality, 2020-2028 (US$ Million)
10.1.1.2.4 Japan: ECMO Market, by Application, 2020-2028 (US$ Million)
10.1.1.2.5 Japan: ECMO Market, by Age Group, 2020-2028 (US$ Million)
10.1.1.3 India: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: ECMO Market, by Modality, 2020-2028 (US$ Million)
10.1.1.3.4 India: ECMO Market, by Application, 2020-2028 (US$ Million)
10.1.1.3.5 India: ECMO Market, by Age Group, 2020-2028 (US$ Million)
10.1.1.4 South Korea: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 South Korea: ECMO Market, by Modality, 2020-2028 (US$ Million)
10.1.1.4.4 South Korea: ECMO Market, by Application, 2020-2028 (US$ Million)
10.1.1.4.5 South Korea: ECMO Market, by Age Group, 2020-2028 (US$ Million)
10.1.1.5 Australia: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Australia: ECMO Market, by Modality, 2020-2028 (US$ Million)
10.1.1.5.4 Australia: ECMO Market, by Application, 2020-2028 (US$ Million)
10.1.1.5.5 Australia: ECMO Market, by Age Group, 2020-2028 (US$ Million)
10.1.1.6 Rest of APAC: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of APAC: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of APAC: ECMO Market, by Modality, 2020-2028 (US$ Million)
10.1.1.6.4 Rest of APAC: ECMO Market, by Application, 2020-2028 (US$ Million)
10.1.1.6.5 Rest of APAC: ECMO Market, by Age Group, 2020-2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Terumo Group
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MicroPort Scientific Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 LivaNova Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Nipro Medical Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Eurosets S.R.L.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Getinge AB
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Braile Biomedica
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Fresenius Medical Care AG & Co KGaA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 ABIOMED Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
Table 1. APAC ECMO Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. China ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 3. China ECMO Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 4. China ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan ECMO Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
Table 8. India ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 9. India ECMO Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 10. India ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
Table 11. South Korea ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 12. South Korea ECMO Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 13. South Korea ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
Table 14. Australia ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 15. Australia ECMO Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 16. Australia ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of APAC ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of APAC ECMO Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of APAC ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
Table 20. Recent Inorganic Growth Strategies
Table 21. Recent Organic Growth Strategies
Table 22. Glossary of Terms
Figure 1. APAC ECMO Market Segmentation
Figure 2. APAC ECMO Market, By Country
Figure 3. APAC ECMO Market Overview
Figure 4. APAC ECMO Market, By Modality
Figure 5. APAC ECMO Market, By Country
Figure 7. APAC: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Impact Analysis: APAC ECMO Market
Figure 10. APAC ECMO Market - Revenue Forecast and Analysis
Figure 11. APAC ECMO Market Share by Modality 2021 & 2028 (%)
Figure 12. Venoarterial ECMO: APAC ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 13. Venovenous ECMO: APAC ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 14. Arteriovenous ECMO: APAC ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 15. APAC ECMO Market, by Application 2021 & 2028 (%)
Figure 16. Respiratory : APAC ECMO Market Revenue and Forecasts To 2028 (US$ MN)
Figure 17. Cardiology : APAC ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. APAC ECMO Market, by Age Group 2021 & 2028 (%)
Figure 19. Adults : APAC ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Pediatrics : APAC ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Neonates : APAC ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. APAC: ECMO Market, by Key Country - Revenue (2021) (US$ Million)
Figure 23. APAC: ECMO Market, by Country, 2021 & 2028 (%)
Figure 24. China: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Japan: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. India: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. South Korea: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Australia: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Rest of APAC: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ABIOMED Inc
- Braile Biomedica
- Eurosets S.R.L.
- Fresenius Medical Care AG & Co KGaA
- Getinge AB
- LivaNova Plc
- Medtronic Plc
- MicroPort Scientific Corporation
- Nipro Medical Corporation
- Terumo Group
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 129 |
| Published | January 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 110.85 Million |
| Forecasted Market Value ( USD | $ 139.19 Million |
| Compound Annual Growth Rate | 3.9% |
| Regions Covered | Asia Pacific |
